ACG Clinical Guideline: Gastroparesis
2022/06/03 by Michael Camilleri, Braden Kuo, Linda Anh B. Nguyen +8 · 29 citations
Medicine · #Gastrointestinal motility and disorders #Intestinal and Peritoneal Adhesions #Diet and metabolism studies
paper · doi:10.14309/ajg.0000000000001874
Abstract
Gastroparesis is characterized by symptoms suggesting retention of food in the stomach with objective evidence of delayed gastric emptying in the absence of mechanical obstruction in the gastric outflow. This condition is increasingly encountered in clinical practice. These guidelines summarize perspectives on the risk factors, diagnosis, and management of gastroparesis in adults (including dietary, pharmacological, device, and interventions directed at the pylorus), and they represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation process. When the evidence was not appropriate for Grading of Recommendations, Assessment, Development, and Evaluation, we used expert consensus to develop key concept statements. These guidelines should be considered as preferred but are not the only approaches to these conditions.
Citations
Cited by
- AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review
- Systematic review of endoscopic botulinum toxin injections for refractory gastroparesis
- GLP‐1 Receptor Agonists and Endoscopy: Understanding Gastric Stasis, Aspiration Risk, and Contemporary Peri‐Procedural Guidance
- Endoscopic and surgical treatment options for gastroparesis: systematic review and network meta-analysis
- Ten controversies in gastroparesis and a look to the future. [europepmc]
- Endoscopic Intrapyloric Botulinum Toxin Injection with Pyloric Balloon Dilation for Symptoms of Delayed Gastric Emptying after Distal Esophagectomy for Esophageal Cancer: A 10-Year Experience. [europepmc]
- Assessment and management of disorders of gut-brain interaction in patients with eating disorders. [europepmc]
- Diagnostic Methods for Evaluation of Gastric Motility-A Mini Review. [europepmc]
- Electroceuticals for Neurogastroenterology and Motility Disorders. [europepmc]
- Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the Disease. [europepmc]
- A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis. [europepmc]
- Gastric Alimetry in the Management of Chronic Gastroduodenal Disorders: Impact to Diagnosis and Health Care Utilization. [europepmc]
- Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment. [europepmc]
- Prevalence of gastroparesis in diabetic patients: a systematic review and meta-analysis. [europepmc]
- A pilot genome-wide association study meta-analysis of gastroparesis. [europepmc]
- miR-10b-5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes. [europepmc]
- Effects of GLP-1 and Other Gut Hormone Receptors on the Gastrointestinal Tract and Implications in Clinical Practice. [europepmc]
- Gastric Alimetry Expands Patient Phenotyping in Gastroduodenal Disorders Compared with Gastric Emptying Scintigraphy. [europepmc]
- The Gut-brain Connection and Episodic Migraine: an Update. [europepmc]
- Gastroparesis might not be uncommon in patients with diabetes mellitus in a real-world clinical setting: a cohort study. [europepmc]
- In silico modelling of the effect of pyloric intervention procedures on gastric flow and emptying in a stomach with gastroparesis. [europepmc]
- Sustained Effectiveness and Safety of Therapeutic miR-10a/b in Alleviating Diabetes and Gastrointestinal Dysmotility without Inducing Cancer or Inflammation in Murine Liver and Colon. [europepmc]
- The Association between Hormone Replacement Therapy and Gastroparesis in Post-Menopausal Women: A Worldwide Database Analysis. [europepmc]
- Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management. [europepmc]
- Gastric Alimetry® Testing and Healthcare Economic Analysis in Nausea and Vomiting Syndromes. [europepmc]
- Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated Review. [europepmc]
- Functional dyspepsia and gastroparesis: are they distinct disorders, a spectrum of diseases or one disease? [europepmc]
- Pyloric Dysfunction: A Review of the Mechanisms, Diagnosis, and Treatment. [europepmc]
- 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026. [europepmc]
Related